Covered recipient · General Payments record
KABIR K DAS
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2025
$2,749.03
- Reported across 173 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $330.05 | 16 |
| Education | $16.27 | 1 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $183.04 | 9 |
| Lilly USA, LLC | $46.63 | 2 |
| PFIZER INC. | $23.46 | 1 |
| GlaxoSmithKline, LLC. | $20.78 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $20.77 | 1 |
| Globus Medical, Inc. | $19.59 | 1 |
| Merck Sharp & Dohme Corporation | $16.65 | 1 |
| Medtronic, Inc. | $15.40 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $20.77 | 05/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1225510480 | CMS |
| GlaxoSmithKline, LLC. | $20.78 | 08/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1191413695 | CMS |
| Globus Medical, Inc. | $19.59 | 05/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250102107 | CMS |
| Lilly USA, LLC | $18.66 | 07/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186730579 | CMS |
| Lilly USA, LLC | $27.97 | 08/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186709635 | CMS |
| Medtronic, Inc. | $15.40 | 02/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1219006390 | CMS |
| Merck Sharp & Dohme LLC | $16.65 | 08/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238153446 | CMS |
| Novo Nordisk Inc | $23.19 | 02/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189140012 | CMS |
| Novo Nordisk Inc | $22.17 | 04/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188380443 | CMS |
| Novo Nordisk Inc | $16.27 | 04/29/2025 | Education | Undisputed | 06/30/2026 | 1189081403 | CMS |
| Novo Nordisk Inc | $19.41 | 04/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189068564 | CMS |
| Novo Nordisk Inc | $30.34 | 07/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189087717 | CMS |
| Novo Nordisk Inc | $23.44 | 07/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188447167 | CMS |
| Novo Nordisk Inc | $17.34 | 08/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189045981 | CMS |
| Novo Nordisk Inc | $15.45 | 08/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188833887 | CMS |
| Novo Nordisk Inc | $15.43 | 11/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189147413 | CMS |
| PFIZER INC. | $23.46 | 09/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229496289 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.